Get the Stockscreener App
4.77
10.16%
0.44
After Hours:
4.67
-0.10
-2.10%
Outset Medical Inc stock is traded at $4.77, with a volume of 194.64K.
It is up +10.16% in the last 24 hours and up +18.95% over the past month.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
See More
Previous Close:
$4.33
Open:
$4.38
24h Volume:
194.64K
Relative Volume:
0.95
Market Cap:
$88.38M
Revenue:
$119.48M
Net Income/Loss:
$-81.65M
P/E Ratio:
-0.7009
EPS:
-6.8055
Net Cash Flow:
$-47.13M
1W Performance:
+10.42%
1M Performance:
+18.95%
6M Performance:
-62.02%
1Y Performance:
-59.51%
1-Day Range:
$4.35
$4.79
1-Week Range:
$4.11
$4.79
52-Week Range:
$3.00
$21.98
Outset Medical Inc Stock (OM) Company Profile
Name
Outset Medical Inc
Sector
Industry
Phone
669-231-8200
Address
3052 ORCHARD DRIVE, SAN JOSE
Compare OM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
4.77 | 80.23M | 119.48M | -81.65M | -47.13M | -6.8055 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jun-21-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-08-24 | Initiated | BTIG Research | Buy |
| Apr-05-24 | Upgrade | CL King | Neutral → Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-17-23 | Initiated | CL King | Neutral |
| Nov-11-22 | Initiated | RBC Capital Mkts | Outperform |
| Jul-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-17-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-18-21 | Initiated | Cowen | Outperform |
| Apr-19-21 | Initiated | Wells Fargo | Overweight |
| Dec-16-20 | Initiated | Oppenheimer | Perform |
| Oct-12-20 | Initiated | Barclays | Overweight |
| Oct-12-20 | Initiated | BofA Securities | Buy |
| Oct-12-20 | Initiated | Goldman | Buy |
| Oct-12-20 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-12-20 | Initiated | SVB Leerink | Mkt Perform |
| Oct-12-20 | Initiated | Stifel | Buy |
View All
Outset Medical Inc Stock (OM) Latest News
Outset Medical (OM) price target decreased by 14.29% to 9.18 - MSN
Reid Health team targets manual charting reductions through Outset Medical EMR integration - Traders Union
Outset Medical (OM) to Release Quarterly Earnings on Wednesday - MarketBeat
Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026 - The Manila Times
Outset Medical sets May 7 investor call with CEO, CFO - Stock Titan
Outset Medical Q4 2025 earnings preview - MSN
Outset Medical (NASDAQ: OM) details 2026 meeting, board elections and exec pay - Stock Titan
Does Outset Medical (OM) stock justify its current price (Near Highs) 2026-04-20Insider Info - Cổng thông tin điện tử Tỉnh Sơn La
AI Models Turn Cautiously More Positive on Outset Medical as Turnaround Takes Shape - TipRanks
Should investors consider Outset Medical (OM) stock right now (Technical Strength) 2026-04-18Swing Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Outset Medical, Inc. (OM) Stock Analysis: Exploring a Healthcare Play with 106.90% Potential Upside - DirectorsTalk Interviews
RBC Capital Keeps Their Hold Rating on Outset Medical (OM) - The Globe and Mail
RBC Capital Maintains Outset Medical(OM.US) With Hold Rating, Maintains Target Price $7 - Moomoo
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - GuruFocus
Outset Medical (NASDAQ:OM) Stock Rating Lowered by Wall Street Zen - MarketBeat
Outset Medical, Inc. (NASDAQ:OM) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Is Outset Medical (OM) Stock Showing Strength | Price at $4.18, Down 0.48%Community Picks - Xã Thanh Hà
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule - National Today
Outset Medical Reports Nasdaq Inducement Grant - National Today
Outset Medical (OM) EVP granted 96,000 restricted stock units in equity award - Stock Titan
Outset Medical (OM) EVP Elliott Derick A. files initial Form 3 insider report - Stock Titan
Outset Medical gives new commercial chief 96,000 stock units - Stock Titan
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Outset Medical, Inc. (NASDAQ:OM) Position Lowered by National Bank of Canada FI - 富途牛牛
TD Cowen Initiates Outset Medical(OM.US) With Buy Rating, Announces Target Price $12 - Moomoo
Outset Medical adds former Stryker leader as new EVP of commercial - MassDevice
Outset Medical names Derick Elliott commercial chief By Investing.com - Investing.com Canada
Outset Medical Names Derick Elliott as Executive Vice President of Commercial - National Today
Outset Medical names Derick Elliott commercial chief - Investing.com
Outset brings in ex-Stryker leader as Tablo expands across hospitals - Stock Titan
Outset Medical, Inc. Appoints Derick Elliott as Executive Vice President of Commercial, Effective April 6, 2026 - marketscreener.com
Market Moves: Is Outset Medical Inc stock risky to hold nowTrade Performance Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
Should I Hold Outset Medical (OM) Stock Now | Price at $4.07, Up 1.50%Post Earnings - Cổng thông tin điện tử tỉnh Lào Cai
OM Stock Analysis: Outset Medical Inc gains 4.43 pct to hit 4.01 price point - Xã Thanh Hà
Outset Medical, Inc. (OM) Stock Analysis: Exploring a 173% Potential Upside with Innovative Hemodialysis Solutions - DirectorsTalk Interviews
OM PE Ratio & Valuation, Is OM Overvalued - Intellectia AI
Outset Medical Gets Investor Suit Over Device Approval Trimmed - Bloomberg Law News
ETF Watch: Can Outset Medical Inc sustain earnings growthWeekly Risk Report & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Outset Medical (NASDAQ:OM) Upgraded at Wall Street Zen - MarketBeat
Vanguard realigns reporting; Outset Medical (OM) shows 0% stake - Stock Titan
Resistance Check: What is Outset Medical Incs 5 year growth outlookRecession Risk & Daily Technical Forecast Reports - baoquankhu1.vn
If You Invested $1,000 in Outset Medical, Inc. (OM) - Stock Titan
OM Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
OM.O Technical Analysis & Stock Price Forecast - Intellectia AI
Outset Medical to detail in-house dialysis rollout and nurse impact at AONL2026 - Traders Union
OM SEC FilingsOutset Medical, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Outset Medical, Inc. (OM) Stock Analysis: Exploring a 213% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Why Did Outset Medical Stock Tumble Today? - MSN
Outset Medical bets on workflow efficiency gains with Tablo Dialysis during AONL2026 - tradersunion.com
Analyst sentiment on Outset Medical (OM) remains strong following Q4 results - MSN
Short Interest in Outset Medical, Inc. (NASDAQ:OM) Drops By 13.6% - MarketBeat
Outset Medical Inc Stock (OM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):